← All stocks

Inmune Bio, Inc.

INMB Net selling
CIK 0001711754 #4623 in the set updated 21 Sep 2026
Bought (120 mo)
$1.48M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.24M
$110.09K on a plan · $0.00 straight out of an exercise
Sold at will
$5.13M
22 of 23 sales
Net
−$3.75M
−$3.64M against sales at will

By person

8 insiders · 69 transactions
16.4×

David J. Moss holds 16.4 times base salary in stock. $6.85M of shares against $416.27K in salary for 2025.

Salary from the company's own proxy. The shares are what David J. Moss last reported holding, valued at $5.29, the price Common Stock was last bought or sold at on the open market here, on 30 Sep 2024.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Schroeder Timothy j
Director
$1.69M (6)
−$1.69M
174,374
0.6283%
$921.88K
−32.6%
Tesi Raymond Joseph
President and CEO
$334.37K (18)
$1.28M (5)
−$942.86K
1,554,106
5.60%
$8.22M
+3.7%
Lowdell Mark William
Chief Scientific Officer
$18.18K (1)
$673.87K (5)
−$655.69K
1,518,017
5.47%
$8.03M
+1.0%
Powers Linda F
10% owner
$615.00K (2)
$1.01M (1)
−$397.00K
910,000
3.28%
$4.81M
−14.0%
Moss David J
Chief Executive Officer
$308.55K (13)
$586.70K (6)
−$278.15K
1,294,883
4.67%
$6.85M
+7.4%
Juda Scott
Director
$208.88K (6)
+$208.88K
158,007
0.5693%
$835.35K
+87.9%
Xencor Inc entity
10% owner
1,885,533
6.79%
$9.97M
+6.1%
Ganjei James Kelly
Director
17,793
0.0641%
$94.07K
Insider
Date
Role
Action
Shares
Price
Amount
Moss David J
2 Jul 2026
Chief Executive Officer
Exercised, kept
9,014
$1.40
$12.62K
Lowdell Mark William
2 Jul 2026
Chief Scientific Officer
Exercised, kept
7,211
$1.40
$10.10K
Juda Scott
2 Jul 2026
Director
Exercised, kept
14,801
$1.40
$20.72K
Xencor Inc
3 Sep 2021
10% owner
Exercised, kept
108,000
$7.80
$842.40K
Tesi Raymond Joseph
25 Aug 2021
President and CEO
Exercised, kept
30,000
$3.91
$117.30K
Moss David J
16 Jul 2021
CFO, Treasurer & Secretary
Exercised, kept
25,000
$3.91
$97.75K

What was left out

Form 4 filings counted 118
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 549,540
Sales filed before the plan box existed 22
History held since 6 May 2019